Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma
The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
Merck Among 10 Companies To Announce Annual Dividend Increases In Second Half Of November
I expect 10 companies to announce their annual increases in the second half of November. Click here for a detailed analysis.
TipRanks on MSN21h
Sichuan Kelun-Biotech Gains Approval for SKB571 Trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update. Sichuan Kelun-Biotech ...
TipRanks on MSN21h
Sichuan Kelun-Biotech’s SKB535 Gains Crucial Drug Approval
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update. Sichuan Kelun-Biotech ...